Daniel Rampersad, PharmD, BCIDP (@rampicillin) profile picture

ID/ASP PharmD | Brooklyn, NY | PGY-2 Infectious Diseases @sunydownstate | PGY-1 @maimopharmres #TwitteRx #IDTwitter Views/Tweets are my own.

Joined February 2022
Photo by Daniel Rampersad, PharmD, BCIDP (@rampicillin)Photo by Daniel Rampersad, PharmD, BCIDP (@rampicillin)Photo by Daniel Rampersad, PharmD, BCIDP (@rampicillin)Photo by Daniel Rampersad, PharmD, BCIDP (@rampicillin)Photo by Daniel Rampersad, PharmD, BCIDP (@rampicillin)Photo by Daniel Rampersad, PharmD, BCIDP (@rampicillin)Photo by Daniel Rampersad, PharmD, BCIDP (@rampicillin)Photo by Daniel Rampersad, PharmD, BCIDP (@rampicillin)Photo by Daniel Rampersad, PharmD, BCIDP (@rampicillin)Photo by Daniel Rampersad, PharmD, BCIDP (@rampicillin)
🆕🔥 Review Article @PharmacoJournal by many 🌟s @SERGE_45_ABX @BBookstaver_USC @blandman19 A review of antibiotic safety in pregnancy —2025 update #IDXposts accpjournals.onlinelibrary.w…
72
2
179
16,725
Daniel Rampersad, PharmD, BCIDP retweeted
Still using clindamycin for necrotizing SSTIs? Time to consider the switch to linezolid: 🦠Similar toxin inhibition 💩 Better AE profile (⬇️ C. Diff ) 2 for 1: no vancomycin (🙅‍♀️ AKI) 🧫No ⬆️ resistance ⁦@MGottliebMD⁩ ⁦@AnnalsofEM⁩ sciencedirect.com/science/ar…
2
21
1
84
6,863
Daniel Rampersad, PharmD, BCIDP retweeted
Effects of cancer therapy on AMR Cisplatin➡️cross-resistance to FQ (target bacterial DNA) Methotrexate➡️dihydrofolate reductase mutations➡️co-select for β-lactams/AG/fosfo resistance Anthracyclines➡️efflux pump expression Etoposide➡️oxidative stress➡️gyrA mutations doi.org/10.1016/j.lanmic.202…
26
49
2,607
Switching to an oral azole (fluconazole or voriconazole) is moderately recommended after 5 or more days of echinocandin treatment in patients meeting the following criteria 👇 #idxposts
🔥Just published🔥 @TheLancetInfDis @CornelyOliver @RosanneSprute Global guideline for the diagnosis and management of candidiasis: an an initiative of the @eurconfmedmycol in cooperation with @ISHAM_Mycology & @ASMicrobiology thelancet.com/journals/lanin…
35
89
10,172
Daniel Rampersad, PharmD, BCIDP retweeted
MYCOPLASMA PNEUMONIAE This cheeky little intracellular bacteria seems to be up to mischief with kids in the USA at the moment A quick thread on this bug, what's going on, and what to do (or not do!) about it 1/🧵
14
128
8
580
166,936
Daniel Rampersad, PharmD, BCIDP retweeted
1/2 Dr. Shruti Gohil @UCIrvineHealth presented INSPIRE data on intra-abdominal infections (IAIs) at #IDWeek2024. IAIs involve diverse organs/spaces. Yet, only 1% (+) for MRSA and another 1% (+) for Pseudomonas, despite 63% of patients getting empiric broad-spectrum abx treatment.
1
30
1
79
11,548
Daniel Rampersad, PharmD, BCIDP retweeted
More is not always better. Adding vancomycin to cefazolin as surgical prophylaxis in patients undergoing arthroplasty does not improve outcomes in patients not known to be MRSA colonized. Outcomes WORSE for knee arthroplasty. Just don't. nejm.org/doi/10.1056/NEJMoa2… #IDWeek2024
1
48
126
10,372
Daniel Rampersad, PharmD, BCIDP retweeted
Good board review on Candida treatment. #IDWeek2024
1
163
5
442
42,191
Daniel Rampersad, PharmD, BCIDP retweeted
Replying to @IDPharmD_Kate
@IDPharmD_Kate crushing it & getting everyone talking about, is this really AKI when it comes to vanco + pip/tazo? And coining the term fake-KI 🤩 Her key lesson…we probably don’t need vanco (or pip/tazo) for most patients! #IDWeek2024 #SIDP2024
2
22
3
85
6,624
Daniel Rampersad, PharmD, BCIDP retweeted
Replying to @CIDJournal
👏👏👏
1
11
40
2,958
Daniel Rampersad, PharmD, BCIDP retweeted
Me on ICU rounds when someone says we can’t use linezolid because the patient is on an SSRI
6
16
4
170
12,777
Daniel Rampersad, PharmD, BCIDP retweeted
It's your favorite post of the month- the articles of interest for August! With a few from June and July 😊🦠
2
35
153
26,854
Learned something new today 😳
Replying to @EM_RESUS
Used to see this at the VA years ago. Some hospitals used ping pong balls to treat tuberculosis (TB) by inserting them into a patient's chest cavity- plombage. If I'm wrong, I'll try to stick to cardiology 🤷
2
69
Daniel Rampersad, PharmD, BCIDP retweeted
If you’re wondering, “But wait, how do I know the pre-test probability for bacteremia in common infectious diseases?” Well, @ValeriaFabreMD covers some of these in this must-read scoping review! academic.oup.com/cid/article…
Now that we’re on the topic: Isolated fever is a POOR predictor of bacteremia. Shaking chills are better indicators. HOWEVER, you also need to consider the pre-test probability based on the syndrome in question. jamanetwork.com/journals/jam…
1
42
2
119
20,233
Daniel Rampersad, PharmD, BCIDP retweeted
💩 additional evidence that cefepime causes more CDiff than piptazo 💩theoretically piptazo has anaerobic coverage so you might assume that it should cause more CDiff.. but it doesn't 💩 this is why we need EBM, not handwaving about saving the anaerobes sciencedirect.com/science/ar…
6
28
2
141
12,378
Daniel Rampersad, PharmD, BCIDP retweeted
It's here! 100th #Breakpoints Episode: Drs. Jeffrey Pearson & Jason Pogue join Dr. Jeannette Bouchard as they take on all things tetracyclines. Do not miss this one! This podcast was supported by an unrestricted grant from Paratek Pharmaceuticals Inc. 🎧 sidp.pinecast.co
1
30
6
72
19,964
Daniel Rampersad, PharmD, BCIDP retweeted
Replying to @ABsteward
Most often, the best « agent » against S.maltophilia is a good I.D. doc who says « this is not an infection, it’s colonization (probably selected because of the unjustified ATB overuse over the last few weeks »)
3
7
44
1,910